A recent study from AMRA Medical and the University of Oslo sheds light on the impact of antidepressants, specifically SSRIs and TCAs, on muscle health and cardiometabolic risk. This research is particularly relevant given the rising global use of antidepressants and their potential adverse effects.
The study, conducted as part of the CoMorMent project, analyzed data from the UK Biobank database, focusing on SSRI and TCA users. The findings revealed that SSRI users, compared to a control group, exhibited higher visceral fat, reduced muscle volume, and increased muscle fat infiltration. While female SSRI users experienced a greater increase in BMI over time, male users demonstrated a more concerning body composition profile and elevated cardiovascular disease risk. Similarly, TCA users showed unfavorable muscle composition compared to the control group, with both genders exhibiting an increased risk of developing Type 2 Diabetes.
AMRA Medical’s innovative muscle volume and fat z-scores were instrumental in this research. These scores, derived from whole-body MRI scans, provide a nuanced understanding of individual deviations from expected body composition norms, going beyond traditional metrics like BMI. The study highlights the importance of these z-score biomarkers in evaluating individual responses to antidepressants and emphasizes the often-overlooked role of body fat distribution and muscle composition in antidepressant treatment.
AMRA Medical aims to utilize these findings to pave the way for future studies focused on improving mental and cardiometabolic health for antidepressant users. The company is dedicated to applying its z-score methodology across various disease areas, including studying neuropsychiatric drugs with metabolic effects. This commitment seeks to aid in developing targeted and effective treatments while minimizing potential risks.
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.
